Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) Invested Capital (2019 - 2025)

Historic Invested Capital for Pharming (PHAR) over the last 4 years, with Q3 2022 value amounting to $143000.0.

  • Pharming's Invested Capital fell 6358.57% to $143000.0 in Q3 2022 from the same period last year, while for Jun 2023 it was $143000.0, marking a year-over-year decrease of 8361.18%. This contributed to the annual value of $165875.8 for FY2021, which is 117.07% down from last year.
  • Pharming's Invested Capital amounted to $143000.0 in Q3 2022, which was down 6358.57% from $152000.0 recorded in Q2 2022.
  • Over the past 5 years, Pharming's Invested Capital peaked at $392702.7 during Q3 2021, and registered a low of $143000.0 during Q3 2022.
  • Its 4-year average for Invested Capital is $208130.5, with a median of $175266.6 in 2020.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 535.8% in 2021, then crashed by 6358.57% in 2022.
  • Over the past 4 years, Pharming's Invested Capital (Quarter) stood at $296645.9 in 2019, then tumbled by 40.92% to $175266.6 in 2020, then decreased by 5.36% to $165875.8 in 2021, then decreased by 13.79% to $143000.0 in 2022.
  • Its last three reported values are $143000.0 in Q3 2022, $152000.0 for Q2 2022, and $162000.0 during Q1 2022.